Enabling Commercial-Ready LVV and EV
Manufacturing Through Process Intensification
Presenter:
Jae Jung
Process Development Scientist,
RoosterBio
Jae is a process development scientist at RoosterBio, specializing in development of scalable downstream processes for MSC and MSC-EVs. Jae has more than four years of direct experience in leading the process development efforts for both internal R&D and external development services clients.
Keen Chung, PhD
Associate Director of R&D for Viral Vector Culture and Analytics,
Repligen
Keen Chung, PhD, is associate director of R&D for viral vector culture and analytics within the advanced bioprocess applications group at Repligen. He has over ten years of industry experience in viral vector upstream process development and bioanalytical characterization for gene therapy manufacturing. Keen holds a doctoral degree in molecular toxicology from the Penn State University College of Medicine and completed postdoctoral training at UT Southwestern Medical Center and SRI International.
Prior to Repligen, he held scientific leadership roles at Pall Life Sciences, where he led analytical and upstream process development efforts supporting the optimization and scale-up of multiple viral vector manufacturing platforms. In his current role, Keen leads the development of advanced bioprocess technologies, with a focus on TFDF-based perfusion systems and viral vector analytics for cell and gene therapy applications.
